StockData
Alvotech logo

Alvotech (ALVO) stock

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.37−0.04 (-0.79%)

Close on Nov 17, 2026Market cap $1.36BP/E 43.7Yield –

Alvotech total assets

Total assets on the balance sheet at the end of each period.

Alvotech's total assets was $1.59B at Jun 30, 2026. For fiscal 2025 it was $1.49B, up 21.8% from the year before. The highest annual figure on record is $1.49B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.49B+21.8%
FY2024Dec 31, 2024$1.22B+28.6%
FY2023Dec 31, 2023$950.09M+14.7%
FY2022Dec 31, 2022$828.44M+38.5%
FY2021Dec 31, 2021$597.98M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.59B+48.6%
Q4 FY2025Dec 31, 2025$1.49B+56.5%
Q2 FY2025Jun 30, 2025$1.39B+52.9%
Q4 FY2024Dec 31, 2024$1.22B+47.4%
Q2 FY2024Jun 30, 2024$1.07B+78.7%
Q4 FY2023Dec 31, 2023$950.09M–
Q2 FY2023Jun 30, 2023$910.66M–
Q4 FY2022Dec 31, 2022$828.44M–
Q4 FY2021Dec 31, 2021$597.98M–

More Alvotech figures

See a number that looks wrong?